Early Alzheimer's disease was diagnosed in this study by considering characteristics associated with specific AD medications such as calcium, vitamin D supplements, blood thinner medicines, cholesterol-lowering drugs, and cognitive drugs, including a substantial protein biomarker (Aβ, tau, and ptau) as a predictor. The gene discussed is MAPT; the disease is Alzheimer disease.